Short Interest in Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Expands By 106.3%

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the recipient of a large increase in short interest in February. As of February 13th, there was short interest totaling 5,748 shares, an increase of 106.3% from the January 29th total of 2,786 shares. Based on an average trading volume of 31,320 shares, the days-to-cover ratio is presently 0.2 days. Based on an average trading volume of 31,320 shares, the days-to-cover ratio is presently 0.2 days.

Alpha Tau Medical Stock Performance

Shares of DRTSW traded down $0.16 on Friday, reaching $1.21. The company’s stock had a trading volume of 39,846 shares, compared to its average volume of 64,540. The stock’s 50 day simple moving average is $0.84 and its two-hundred day simple moving average is $0.50. Alpha Tau Medical has a 12-month low of $0.13 and a 12-month high of $1.50.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.